<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
</head>
<body>
Thank you, the Cell example is helpful.<br>
<br>
If you look up Cell on Sherpa Romeo you will see that authors can self-archive their preprint on noncommercial servers such as arXiv and bioRxiv at no cost and with no delay: https://www.sherpa.ac.uk/romeo/search.php?source=journal&sourceid=6580&la=en&fIDnum=|&mode=simple<br>
<br>
In brief: this is what I recommend to authors and funders.<br>
<br>
Details:<br>
<br>
Relyx (Elsevier's parent company) is a corporation with a mandate to return profit to shareholders. In the case of Cell, revenue and profit is derived from selling the journal through subscriptions and selling re-use rights. For-profit scholarly publishers
by definition must make a profit.<br>
<br>
181 USD for the use of 5 figures is a model of transparency and a bargain in comparison with legally obligatory non-transparent blanket licensing as Canada's copyright collectives are demanding for limited rights that might not cover this case.<br>
<br>
If the figures are in an arXiv version and the downstream author cannot afford the 181 USD, they can cite the arXiv version at no cost. There is a small cost in inconvenience, but no loss of knowledge.
<br>
<br>
Elsevier appears to be interpreting NC as necessary to their downstream commercial re-use rights. This is a matter of interpretation. NC/ND with author copyright means authors retain these rights, not publishers. CC licenses with no NC grant blanket commercial
rights to anyone. Under CC-BY for example, anyone could charge whatever they like for the 5 figures. Whether they could do this through CCC per se depends on CCC policy and practice, not the license. With blanket downstream commercial rights, anyone can set
up a for-pay image database. <br>
<br>
My recommendation: authors of Cell articles should self-archive preprints for open access and take advantage of pre-submission peer review (a community practice in arXiv) in order to post a preprint that has been peer reviewed. For the future: further develop
this model and eliminate the role of the for-profit publisher.<br>
<br>
I do not recommend paying for Elsevier postprint OA under any license. Their use of NC and ND is problematic. but so is their use of CC-BY.<br>
<br>
best,<br>
<br>
Dr. Heather Morrison<br>
Associate Professor, School of Information Studies, University of Ottawa<br>
Professeur Agrégé, École des Sciences de l'Information, Université d'Ottawa<br>
Principal Investigator, Sustaining the Knowledge Commons, a SSHRC Insight Project<br>
sustainingknowledgecommons.org<br>
Heather.Morrison@uottawa.ca<br>
https://uniweb.uottawa.ca/?lang=en#/members/706<br>
[On research sabbatical July 1, 2019 - June 30, 2020]<br>
<hr style="display:inline-block;width:98%" tabindex="-1">
<div id="divRplyFwdMsg" dir="ltr"><font face="Calibri, sans-serif" style="font-size:11pt" color="#000000"><b>From:</b> goal-bounces@eprints.org <goal-bounces@eprints.org> on behalf of Peter Murray-Rust <pm286@cam.ac.uk><br>
<b>Sent:</b> Thursday, September 12, 2019 5:02:15 PM<br>
<b>To:</b> Global Open Access List (Successor of AmSci) <goal@eprints.org><br>
<b>Subject:</b> Re: [GOAL] Call for applications - International Open Access Advisory Group</font>
<div> </div>
</div>
<div>
<div style="font-size:9pt; font-family:'calibri'; color:#FF4233"><b>Attention : courriel externe | external email</b></div>
<div>
<div dir="ltr">
<div>Typical example,</div>
<div>Skimmed through Cell to the first CC - NC - ND article:<br>
<br>
<p style="box-sizing:border-box; margin-top:10px; margin-bottom:18px">DOI: <a href="https://doi.org/10.1016/j.cell.2019.05.055" style="box-sizing:border-box; background-color:transparent; color:rgb(0,87,137); text-decoration-line:none; border-bottom:2px solid rgb(235,235,235)">https://doi.org/10.1016/j.cell.2019.05.055</a></p>
<h3 style="box-sizing:border-box; margin-top:0px; margin-bottom:12px; font-weight:400; font-size:1.1rem; color:rgb(0,87,137)">
Copyright</h3>
<div class="x_gmail-copyright" style="box-sizing:border-box">© 2019 The Author(s). Published by Elsevier Inc.</div>
<h3 style="box-sizing:border-box; margin-top:0px; margin-bottom:12px; font-weight:400; font-size:1.1rem; color:rgb(0,87,137)">
User License</h3>
<a href="http://creativecommons.org/licenses/by-nc-nd/4.0/" class="x_gmail-userLicLnk" style="box-sizing:border-box; background-color:transparent; color:rgb(0,87,137); text-decoration-line:none; border-bottom:2px solid rgb(235,235,235)">Creative Commons Attribution
– NonCommercial – NoDerivs (CC BY-NC-ND 4.0)</a> |
<div class="x_gmail-dropBlock x_gmail-reference-citations" style="box-sizing:border-box; display:inline-block">
<a href="https://www.cell.com/cell/fulltext/S0092-8674(19)30626-9#" class="x_gmail-reference-citations__ctrl" style="box-sizing:border-box; background-color:transparent; color:rgb(0,87,137); text-decoration-line:none; border-bottom:2px solid rgb(235,235,235)">How
you can reuse</a> <img alt="Information Icon" class="x_gmail-infoIcon" style="box-sizing:border-box; border-style:none; max-width:100%" src="https://www.cell.com/templates/jsp/_style2/_marlin/images/information.png"></div>
</div>
<div><br>
</div>
Go to RightsLInk<br>
Enter as academic author writing a book with CUP and requiring 5 figures.
<div>CCC requires me to pay 181 USD to Elsevier / CCC</div>
<div>Try it yourself<br>
<br>
<div class="x_gmail_quote">
<div class="x_gmail_attr">It's irrelevant in practice who s the copyright owner , the total transparency is that Elsevier can extort rent for all CC -NC they pubish even if the author has copyright.</div>
<div class="x_gmail_attr">Transparency = daylight robbery</div>
</div>
<div><br>
</div>
-- <br>
<div dir="ltr" class="x_gmail_signature">
<div dir="ltr">
<div>
<div dir="ltr">
<div>"I always retain copyright in my papers, and nothing in any contract I sign with any publisher will override that fact. You should do the same".<br>
</div>
<div><br>
</div>
<div>Peter Murray-Rust<br>
Reader Emeritus in Molecular Informatics<br>
Unilever Centre, Dept. Of Chemistry<br>
University of Cambridge<br>
CB2 1EW, UK<br>
+44-1223-763069</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</div>
</body>
</html>